These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 26558537

  • 1. PANSS-6: a brief rating scale for the measurement of severity in schizophrenia.
    Østergaard SD, Lemming OM, Mors O, Correll CU, Bech P.
    Acta Psychiatr Scand; 2016 Jun; 133(6):436-44. PubMed ID: 26558537
    [Abstract] [Full Text] [Related]

  • 2. The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.
    Østergaard SD, Foldager L, Mors O, Bech P, Correll CU.
    Schizophr Bull; 2018 Feb 15; 44(2):453-462. PubMed ID: 28575321
    [Abstract] [Full Text] [Related]

  • 3. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G, Noisette C, Legrand A, Delahousse J.
    Encephale; 1997 Feb 15; 23(1):10-8. PubMed ID: 9172962
    [Abstract] [Full Text] [Related]

  • 4. Item response analysis of the Positive and Negative Syndrome Scale.
    Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL.
    BMC Psychiatry; 2007 Nov 15; 7():66. PubMed ID: 18005449
    [Abstract] [Full Text] [Related]

  • 5. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I, Chhoumi M, Mechri A.
    Encephale; 2019 Feb 15; 45(1):15-21. PubMed ID: 29195805
    [Abstract] [Full Text] [Related]

  • 6. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, Cipriani A, Leucht S.
    JAMA Psychiatry; 2015 Jan 15; 72(1):14-21. PubMed ID: 25372935
    [Abstract] [Full Text] [Related]

  • 7. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
    Kølbæk P, Blicher AB, Buus CW, Feller SG, Holm T, Dines D, O'Leary KM, Sørensen RS, Opler M, Correll CU, Mors O, Bech P, Østergaard SD.
    Nord J Psychiatry; 2018 Aug 15; 72(6):431-436. PubMed ID: 30037286
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis.
    Citrome L, Meng X, Hochfeld M.
    Schizophr Res; 2011 Sep 15; 131(1-3):75-81. PubMed ID: 21700430
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure.
    Shafer A, Dazzi F.
    J Psychiatr Res; 2019 Aug 15; 115():113-120. PubMed ID: 31128501
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Davidson M, Saoud J, Staner C, Noel N, Luthringer E, Werner S, Reilly J, Schaffhauser JY, Rabinowitz J, Weiser M, Luthringer R.
    Am J Psychiatry; 2017 Dec 01; 174(12):1195-1202. PubMed ID: 28750582
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J, Arango C, Garcia-Garcia M, Rejas J, CLAMORS Study Collaborative Group.
    J Clin Psychiatry; 2010 Mar 01; 71(3):280-6. PubMed ID: 19895779
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia.
    Kozielska M, Pilla Reddy V, Johnson M, de Ridder F, Vermeulen A, Liu J, Groothuis GM, Danhof M, Proost JH.
    Schizophr Res; 2013 May 01; 146(1-3):53-8. PubMed ID: 23434198
    [Abstract] [Full Text] [Related]

  • 13. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D.
    J Nerv Ment Dis; 1992 Nov 01; 180(11):723-8. PubMed ID: 1431824
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan 01; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 15. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, Gurvich C, Gilbert H, Berk M, Davis SR.
    JAMA Psychiatry; 2016 Sep 01; 73(9):947-54. PubMed ID: 27438995
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
    Lin CH, Lin HS, Lin SC, Kuo CC, Wang FC, Huang YH.
    Acta Psychiatr Scand; 2018 Feb 01; 137(2):98-108. PubMed ID: 29280500
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.
    Glick HA, Li P, Harvey PD.
    Schizophr Res; 2015 Aug 01; 166(1-3):110-4. PubMed ID: 26044113
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.